BRPI0518533A2 - 18-metil-19-nor-pregn-4-en-21,17- carbolactona, bem como preparados farmacÊuticos contendo as mesmas - Google Patents
18-metil-19-nor-pregn-4-en-21,17- carbolactona, bem como preparados farmacÊuticos contendo as mesmasInfo
- Publication number
- BRPI0518533A2 BRPI0518533A2 BRPI0518533-5A BRPI0518533A BRPI0518533A2 BR PI0518533 A2 BRPI0518533 A2 BR PI0518533A2 BR PI0518533 A BRPI0518533 A BR PI0518533A BR PI0518533 A2 BRPI0518533 A2 BR PI0518533A2
- Authority
- BR
- Brazil
- Prior art keywords
- methyl
- group
- pregn
- hydrogen atom
- pharmaceutical preparations
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 239000003470 adrenal cortex hormone Substances 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 239000000583 progesterone congener Substances 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
- C07J53/008—3 membered carbocyclic rings in position 15/16
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
18-METIL-19-NOR-PREGN-4-EN-21,17- CARBOLACTONA, BEM COMO PREPARADOS FARMACÊUTICOS CONTENDO AS MESMAS. A presente invenção descreve as novas 18-metil-19-nor-17- pregn-4-en-21,17-carbolactona da fórmula geral (I) na qual Z é um átomo de oxigênio, dois átomos de hidrogênio, um grupamento =NOR ou =NNHSO~ 2~R, na qual R é um átomo de hidrogênio ou um grupo alquila em cadeia linear ou ramificada com 1 até 4 ou 3 até 4 átomos de carbono, R^ 4^ representa um átomo de hidrogênio, um átomo de halogênio, um grupo metila ou um grupo trifluormetila, R^ 6^ e/ou R^ 7^ pode estar na posição a ou <225> e independentes um do outro, representam um grupo alquila em cadeia linear ou ramificada com 1 até 4 ou 3 até 4 átomos de carbono ou R^ 6^ representa um átomo de hidrogênio e R^ 7^ uma grupo alquila em cadeia linear ou ramificada, em posição a ou <225> com 1 até 4 ou 3 até 4 átomos de carbono ou R^ 6^ e R^ 7^ representam cada um átomo de hidrogênio ou R^ 6^ e R^ 7^ representam juntos um grupo metileno em posição a ou <225> ou uma ligação adicional. Os novos compostos dispõem de um efeito gestagênico e corticóide antimineral e são apropriados para a produção de preparados farmacêuticos, por exemplo, para a contracepção oral e para o tratamento de dores pré-, peri- e pós-menopausais.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004063864A DE102004063864A1 (de) | 2004-12-30 | 2004-12-30 | 18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate |
| PCT/EP2005/014205 WO2006072467A1 (de) | 2004-12-30 | 2005-12-30 | 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactone, sowie diese enthaltende pharmazeutische präparate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0518533A2 true BRPI0518533A2 (pt) | 2008-11-25 |
Family
ID=36087369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0518533-5A BRPI0518533A2 (pt) | 2004-12-30 | 2005-12-30 | 18-metil-19-nor-pregn-4-en-21,17- carbolactona, bem como preparados farmacÊuticos contendo as mesmas |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US20090029953A1 (pt) |
| EP (1) | EP1831240B8 (pt) |
| JP (1) | JP5043681B2 (pt) |
| KR (1) | KR20070093443A (pt) |
| CN (1) | CN101128476B (pt) |
| AR (1) | AR052657A1 (pt) |
| AU (1) | AU2005324055A1 (pt) |
| BR (1) | BRPI0518533A2 (pt) |
| CA (1) | CA2594171C (pt) |
| CR (1) | CR9223A (pt) |
| CY (1) | CY1109498T1 (pt) |
| DE (2) | DE102004063864A1 (pt) |
| DK (1) | DK1831240T3 (pt) |
| EA (1) | EA014325B1 (pt) |
| ES (1) | ES2331322T3 (pt) |
| GT (1) | GT200500394A (pt) |
| HK (1) | HK1112627A1 (pt) |
| IL (1) | IL184288A (pt) |
| MX (1) | MX2007008074A (pt) |
| MY (1) | MY145904A (pt) |
| NO (1) | NO20073257L (pt) |
| NZ (1) | NZ556150A (pt) |
| PA (1) | PA8658401A1 (pt) |
| PE (2) | PE20100736A1 (pt) |
| PL (1) | PL1831240T3 (pt) |
| PT (1) | PT1831240E (pt) |
| RS (1) | RS51128B (pt) |
| SI (1) | SI1831240T1 (pt) |
| TW (1) | TW200635942A (pt) |
| UA (1) | UA90496C2 (pt) |
| UY (1) | UY29320A1 (pt) |
| WO (1) | WO2006072467A1 (pt) |
| ZA (1) | ZA200706254B (pt) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006030416A1 (de) * | 2006-06-29 | 2008-01-03 | Bayer Schering Pharma Ag | 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate |
| DE102007027637A1 (de) | 2007-06-12 | 2008-12-18 | Bayer Schering Pharma Aktiengesellschaft | 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
| DE102007027636A1 (de) | 2007-06-12 | 2008-12-18 | Bayer Schering Pharma Aktiengesellschaft | 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
| DE102007027635A1 (de) * | 2007-06-12 | 2008-12-18 | Bayer Schering Pharma Aktiengesellschaft | 17ß-Cyano-19-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
| DE102007063500A1 (de) * | 2007-12-29 | 2009-07-02 | Bayer Schering Pharma Aktiengesellschaft | 17-(1'-Propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
| DE102007063496A1 (de) * | 2007-12-29 | 2009-07-02 | Bayer Schering Pharma Aktiengesellschaft | 15,16-Methylen-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
| DE102007063503A1 (de) | 2007-12-29 | 2009-07-02 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
| DE102007063501A1 (de) * | 2007-12-29 | 2009-07-02 | Bayer Schering Pharma Aktiengesellschaft | 15, 16-Methylen-17-hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
| DE102007063498A1 (de) * | 2007-12-29 | 2009-07-02 | Bayer Schering Pharma Aktiengesellschaft | 15,16-Methylen-steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
| DE102007063495A1 (de) * | 2007-12-29 | 2009-09-17 | Bayer Schering Pharma Aktiengesellschaft | 19-Nor-Steroidderivate mit einer 15α,16α-Methylengruppe und einem gesättigten 17,17-Spirolactonring, deren Verwendung sowie diese Derivate enthaltende Arzneimittel |
| DE102007063499A1 (de) | 2007-12-29 | 2009-07-02 | Bayer Schering Pharma Aktiengesellschaft | Steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
| WO2009111574A2 (en) * | 2008-03-05 | 2009-09-11 | Evestra, Inc. | BISMETHYLENE-17α CARBOLACTONES AND RELATED USES |
| DE102008026793A1 (de) | 2008-06-02 | 2009-12-03 | Bayer Schering Pharma Aktiengesellschaft | C-Ring-substituierte Pregn-4-en-21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate |
| CN101623287B (zh) * | 2008-07-07 | 2012-02-08 | 天津金耀集团有限公司 | 一种屈螺酮类似物的治疗更年期综合症的药物组合物 |
| US8222237B2 (en) * | 2008-11-25 | 2012-07-17 | Evestra, Inc. | Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones |
| WO2010066349A1 (de) * | 2008-12-12 | 2010-06-17 | Bayer Schering Pharma Aktiengesellschaft | Verwendung von 17beta-cyano-19-androst-4-en-derivaten zur herstellung eines arzneimittels in depot-form zur parenteralen anwendung sowie depot-arzneimittel enthaltend 17beta-cyano-19-androst-4-en-derivate zur parenteralen anwendung |
| WO2010066355A1 (de) * | 2008-12-12 | 2010-06-17 | Bayer Schering Pharma Aktiengesellschaft | VERWENDUNG VON 17β- CYANO-19-NOR-ANDROST-4-EN-DERIVATEN ZUR HERSTELLUNG EINES ARZNEIMITTELS IN DEPOT-FORM ZUR PARENTERALEN ANWENDUNG SOWIE DEPOT-ARZNEIMITTEL ENTHALTEND 17β-CYANO-19-NOR-ANDROST-4-EN-DERIVATE ZUR PARENTERALEN ANWENDUNG |
| WO2010066354A1 (de) * | 2008-12-12 | 2010-06-17 | Bayer Schering Pharma Aktiengesellschaft | VERWENDUNG VON 17β-CYANO-18A-HOMO-19-NOR-ANDROST-4-EN-DERIVATEN ZUR HERSTELLUNG EINES ARZNEIMITTELS IN DEPOT-FORM ZUR PARENTERALEN ANWENDUNG SOWIE DEPOT-ARZNEIMITTEL ENTHALTEND 17β-CYANO-18A-HOMO-19-NOR-ANDROST-4-EN-DERIVATE ZUR PARENTERALEN ANWENDUNG |
| WO2012059594A1 (en) | 2010-11-04 | 2012-05-10 | Bayer Pharma Aktiengesellschaft | Mineralcorticoid receptor antagonists for the treatment of corticoid-induced obesity |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3959322A (en) * | 1960-09-22 | 1976-05-25 | Herchel Smith | Synthesis of 13-alkyl-gon-4-ones |
| DE3022337A1 (de) * | 1980-06-11 | 1982-01-07 | Schering Ag Berlin Und Bergkamen, 1000 Berlin | Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen |
| DE3402329A1 (de) * | 1984-01-20 | 1985-08-01 | Schering AG, 1000 Berlin und 4709 Bergkamen | 6,6-ethylen-15,16-methylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate |
| FR2739029B1 (fr) * | 1995-09-21 | 1997-11-21 | Roussel Uclaf | Nouvelle application therapeutique des composes antimineralo-corticoides |
| DE19651000A1 (de) * | 1996-12-01 | 1998-06-04 | Schering Ag | Oxyiminopregnancarbolactone |
-
2004
- 2004-12-30 DE DE102004063864A patent/DE102004063864A1/de not_active Ceased
-
2005
- 2005-12-28 UY UY29320A patent/UY29320A1/es not_active Application Discontinuation
- 2005-12-28 AR ARP050105574A patent/AR052657A1/es unknown
- 2005-12-29 MY MYPI20056249A patent/MY145904A/en unknown
- 2005-12-29 TW TW094147315A patent/TW200635942A/zh unknown
- 2005-12-29 PA PA20058658401A patent/PA8658401A1/es unknown
- 2005-12-29 GT GT200500394A patent/GT200500394A/es unknown
- 2005-12-30 DK DK05850392T patent/DK1831240T3/da active
- 2005-12-30 UA UAA200708684A patent/UA90496C2/ru unknown
- 2005-12-30 EP EP05850392A patent/EP1831240B8/de active Active
- 2005-12-30 BR BRPI0518533-5A patent/BRPI0518533A2/pt not_active IP Right Cessation
- 2005-12-30 JP JP2007548774A patent/JP5043681B2/ja not_active Expired - Fee Related
- 2005-12-30 DE DE502005007723T patent/DE502005007723D1/de active Active
- 2005-12-30 EA EA200701239A patent/EA014325B1/ru not_active IP Right Cessation
- 2005-12-30 KR KR1020077017382A patent/KR20070093443A/ko not_active Application Discontinuation
- 2005-12-30 RS RSP-2009/0443A patent/RS51128B/sr unknown
- 2005-12-30 US US11/813,251 patent/US20090029953A1/en not_active Abandoned
- 2005-12-30 MX MX2007008074A patent/MX2007008074A/es active IP Right Grant
- 2005-12-30 PL PL05850392T patent/PL1831240T3/pl unknown
- 2005-12-30 CA CA2594171A patent/CA2594171C/en not_active Expired - Fee Related
- 2005-12-30 CN CN2005800486803A patent/CN101128476B/zh not_active Expired - Fee Related
- 2005-12-30 WO PCT/EP2005/014205 patent/WO2006072467A1/de active Application Filing
- 2005-12-30 NZ NZ556150A patent/NZ556150A/en not_active IP Right Cessation
- 2005-12-30 SI SI200530803T patent/SI1831240T1/sl unknown
- 2005-12-30 AU AU2005324055A patent/AU2005324055A1/en not_active Abandoned
- 2005-12-30 ES ES05850392T patent/ES2331322T3/es active Active
- 2005-12-30 PT PT05850392T patent/PT1831240E/pt unknown
-
2006
- 2006-01-03 PE PE2009001212A patent/PE20100736A1/es not_active Application Discontinuation
- 2006-01-03 PE PE2006000006A patent/PE20060853A1/es not_active Application Discontinuation
-
2007
- 2007-06-25 NO NO20073257A patent/NO20073257L/no not_active Application Discontinuation
- 2007-06-28 IL IL184288A patent/IL184288A/en not_active IP Right Cessation
- 2007-07-03 CR CR9223A patent/CR9223A/es not_active Application Discontinuation
- 2007-07-27 ZA ZA200706254A patent/ZA200706254B/xx unknown
-
2008
- 2008-07-25 HK HK08108251.9A patent/HK1112627A1/xx not_active IP Right Cessation
-
2009
- 2009-10-15 CY CY20091101073T patent/CY1109498T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0518533A2 (pt) | 18-metil-19-nor-pregn-4-en-21,17- carbolactona, bem como preparados farmacÊuticos contendo as mesmas | |
| BR0210384A (pt) | Heteroarilas multicìclicas substituìdas por quinuclidinas para o tratamento de doença | |
| BR0009486A (pt) | Compostos que contêm uma amida, utilização desses compostos, composição farmacêutica, processo para o tratamento profilático ou terapêutico de, diabetes do tipo ii e processo para a preparação dos compostos | |
| BR0213612A (pt) | Composto, composição farmacêutica, uso do composto e método para tratamento de doença ou condição | |
| TW200609235A (en) | Tetraazabenzo[e]azulene derivatives and analogs thereof | |
| BRPI0414130B8 (pt) | compostos de fenilamida ou piridilamida, seu uso e composições farmacêuticas que os compreendem. | |
| AR036596A1 (es) | Derivados de 4,5-dihidro-1h-pirazol que tienen actividad antagonista de cb1 | |
| BR0312513A (pt) | Derivados de glicosìdeo de tiofeno, processos para a produção dos mesmos, medicamentos que contêm esses compostos e uso dos mesmos | |
| BR0212158A (pt) | Derivados de diarilcicloalquila, processos para a sua preparação e sua aplicação como ativadores de ppar | |
| BRPI0507877A (pt) | derivados de formamida, composição farmacêutica, uso dos mesmos e combinação | |
| BR0210538A (pt) | Derivados de 5-halotriptamina usados como ligantes dos receptores de serotonina 5-ht6 e/ou 5-ht7 | |
| BRPI0408815A (pt) | moduladores alostéricos positivos do receptor nicotìnico da acetilcolina | |
| TW200736189A (en) | Indene derivatives, their preparation and use as medicaments | |
| BRPI0407055A (pt) | Derivados de isotiazol | |
| BRPI0518094A (pt) | uso de um derivado de piridotienopirimidina, composto de um derivado de piridotienopirimidina, composição farmacêutica, método de tratamento de um sujeito que sofre de uma condição patológica ou doença susceptìvel de cura pela inibição da fosfodiesterase 4 e produto de combinação | |
| ECSP089014A (es) | 18-metil-19-nor-androst-4-en-17,17-espiroéteres (18-metil-19-nor-20-espirox-4-en-3-onas), así como preparaciones farmacéuticas que los contienen | |
| MX2010003983A (es) | 5,6-diarilpiridinas sustituidas en la posicion 2 y 3, su preparacion y su uso terapeutico. | |
| BRPI0411092A (pt) | benzo[b]tiofenos substituìdos com 3-arilsulfanila e com 3-heteroarilsulfanila como agentes terapêuticos | |
| BRPI0518117A (pt) | uso de um derivado de piridotienopirimidina, composição farmacêutica, método para o tratamento de um sujeito que sofre de uma condição patológica ou doença susceptìvel de cura pela inibição da fosfodiesterase 4 e produto de combinação | |
| AR002016A1 (es) | Derivados de 3-fenilisoquinoleina-1-(2h)-ona, procedimiento para su preparacion y medicamento y composicion farmaceutica que los contienen. | |
| BRPI0413013A (pt) | composto, seus sais, solvatos, e derivados farmaceuticamente funcionais, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou distúrbios, e de doenças | |
| BR0017023A (pt) | Derivados amino substituìdos ramificados do 3-amino-1-fenil-1h [1,2,4] triazol, processos para o respectivo preparo e composições farmacêuticas que os contêm | |
| NO20055754L (no) | Kolkisosidanaloger | |
| BR0016921A (pt) | Tetrahidropiridinas, processo para sua preparação e composições farmacêuticas que as contêm | |
| BRPI0713439A2 (pt) | derivados aminados de b-homoandrostanos e b-heteroandrostanos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2286 DE 29/10/2014. |